Ketamine-enhanced Prolonged Exposure Therapy in PTSD
Status:
Recruiting
Trial end date:
2024-09-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as
compared to placebo to reduce symptoms of Posttraumatic Stress Disorder (PTSD) among Veteran
receiving Prolonged Exposure Therapy.